CD155 can be expressed by many normal human cell types, but it is upregulated in a variety of tumors, including non-small cell lung cancer (NSCLC), melanoma, colorectal cancer and glioblastoma [55–57]. Here, PVR is linked to non-small cell lung carcinoma.